Haematologica (Jul 2024)
Minimal residual disease assessment in transplant-eligible patients with multiple myeloma: real-world applications of multiparametric flow cytometry-DURAClone (CAREMM-2104)
Abstract
Not available.
Haematologica (Jul 2024)
Not available.